Nanjing, China

Bin Ge

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Medolution Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bin Ge. Retrieved from https://idiyas.com/inventor/bin-ge-pr6qkheo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bin Ge and Pharmaceutical Formulation Innovation.

Introduction

Bin Ge is an inventor associated with Nanjing, China, and Jiangsu Medolution Ltd. His patent work includes a pharmaceutical composition and preparation method involving a substituted crotonamide compound.

Latest Patents

The supplied information identifies one patent for Bin Ge: “Substituted crotonamide pharmaceutical composition and preparation method therefor.” The invention describes a composition containing 5–50 parts of (E)-N-(3-cyano-7-ethoxy-4-(3-ethynylphenylamino)quinolin-6-yl)-4-(dimethylamino)but-2-enamide maleate, 40–120 parts of a carbohydrate filler, 2–20 parts of a disintegrant, 0–6 parts of an adhesive, and 0.5–5 parts of a lubricant. It also describes a method for preparing the composition. The supplied data lists 1 patent for Ge.

Career Highlights

Ge’s listed patent focuses on pharmaceutical formulation, specifying ingredient ranges and excipient categories for a substituted crotonamide composition. The supplied information associates his work with Jiangsu Medolution Ltd.

Collaborations

Haitao Tang and Bei Wang are identified as Ge’s coworkers. The supplied information does not specify their roles in the patent or other collaborative work.

Conclusion

Bin Ge’s listed invention concerns the formulation and preparation of a substituted crotonamide pharmaceutical composition, reflecting his patent-related work in pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…